Skip to main content
Neuropsychiatric Disease and Treatment logoLink to Neuropsychiatric Disease and Treatment
. 2017 Jul 26;13:2003–2004. doi: 10.2147/NDT.S146174

Involvement of up-regulation of miR-210 in a rat epilepsy model [Corrigendum]

PMCID: PMC5536313  PMID: 28794634

Chen L, Zheng H, Zhang S. Involvement of up-regulation of miR-210 in a rat epilepsy model. Neuropsychiatr Dis Treat. 2016;12:1731–1737.

On page 1734, false positive results were displayed in Figure 2B. The correct Figure 2 is as follows:

Figure 2.

Figure 2

miR-210 inhibitor prohibited epilepsy-induced morphological changes.

Notes: (A) Intrahippocampal injection of miR-210 inhibitor reversed miR-210 level induced by epilepsy modeling. **P<0.01 compared with control; ##P<0.01 compared with E group. (B) Hematoxylin and eosin staining indicated that miR-210 inhibitor mitigated the morphological changes caused by epilepsy. Scale bar: 100 µm.

Abbreviations: E, epilepsy; miRI + E, miR-210 inhibitor and epilepsy; V + E, vehicle and epilepsy.

On page 1735, false positive results were displayed in Figure 3. The correct Figure 3 is as follows:

Figure 3.

Figure 3

Figure 3

miR-210 inhibitor prohibited epilepsy-induced neuronal apoptosis.

Notes: (A) Apoptosis detected by Tunel assay with the arrows indicating apoptotic cells. Scale bar: 50 µm. (B) Quantitative data of the apoptosis. **P<0.01 compared with control; ##P<0.01 compared with E group.

Abbreviations: E, epilepsy; miRI + E, miR-210 inhibitor and epilepsy; V + E, vehicle and epilepsy.


Articles from Neuropsychiatric Disease and Treatment are provided here courtesy of Dove Press

RESOURCES